Syngene International Ltd.

₹391.1

-5.3 (-1.3%)

SYNGENE Share Price

HEALTHCARE SERVICES

As on April 2, 2026

SectorHealthcare

IndustryHEALTHCARE SERVICES

Basic IndustryHealthcare Research Analytics & Technology

Market Cap₹ 15,793 Cr

P/E Ratio31.72

Dividend Yield0.03 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	402.35	Bearish
10-DMA	405.09	Bearish
20-DMA	405.86	Bearish
50-DMA	443.43	Bearish
100-DMA	543.54	Bearish
200-DMA	598.03	Bearish

Historical Performance

1 Year

-46%

3 Years

-34.2%

5 Years

-29.9%

10 Years

106.1%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Sales	---	---	---	---	---
Operating Expenses	11,843	10,820	10,788	9,137	6,818
Other Income	718	906	726	1,084	833
Operating Profit	11,136	11,050	10,053	8,489	7,364
Interest	531	472	452	241	277
Depreciation	4,326	4,259	3,665	3,097	2,745
Profit Before Tax	6,599	6,208	5,936	4,844	4,692
Consolidated Net Profit	4,962	5,100	4,644	3,958	4,049
Adjusted EPS	12	13	12	10	10

Compounded Sales Growth

10 Years:20.7

5 Years:12.6

3 Years:6.9

TTM:0.9

Compounded Profit Growth

10 Years:10.2

5 Years:3.8

3 Years:4.6

TTM:-0.5

Stock Price CAGR

10 Years:7.5

5 Years:-6.9

3 Years:-12.6

TTM:-47.7

Return on Equity

10 Years:N/A

5 Years:10.1

3 Years:11.6

last year:12.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	4,025	4,020	4,014	4,008	4,000
Total Reserves	42,449	37,866	31,512	28,093	23,444
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	6,434	7,089	9,552	9,717	8,397
Other Current Liabilities	8,451	7,268	7,782	6,558	5,716
Short Term Borrowings	1,196	417	863	2,581	2,599
Total Liabilities	67,665	61,108	57,614	54,982	47,941
Capital Work in Progress	12,614	8,368	1,769	3,464	2,372
Long Term Loans & Advances	1,964	2,396	1,811	1,512	1,150
Currents Investments	6,105	5,132	8,244	7,638	4,233
Short Term Loans and Advances	1,042	958	747	801	316
Total Current Assets	22,873	19,589	24,253	22,059	18,067
Total Assets	67,665	61,108	57,614	54,982	47,941
Adjusted Book Value	115	104	89	80	69

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 31.72, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -12.6%, indicating poor shareholder returns.
The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹11136 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹36424 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 523455.8

No. of Shares: 1338 (Approx)

Performance:-47.7%

P/L: ₹-476544.2

NIFTY Performance: -2.3%

1 day Top Gainers